Background/Aims: Central blood pressure (BP) has been suggested to be a better estimator of hypertension-associated risks. We aimed to evaluate the association of 24-hour central BP, in comparison with 24-hour peripheral BP, with the presence of renal organ damage in hypertensive patients. Methods: Brachial and central (calculated by an oscillometric system through brachial pulse wave analysis) office BP and ambulatory BP monitoring (ABPM) data and aortic pulse wave velocity (PWV) were measured in 208 hypertensive patients. Renal organ damage was evaluated by means of the albumin to creatinine ratio and the estimated glomerular filtration rate. Results: Fifty-four patients (25.9%) were affected by renal organ damage, displaying either microalbuminuria (urinary albumin excretion ≥30 mg/g creatinine) or an estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m 2 . Compared to those without renal abnormalities, hypertensive patients with kidney damage had higher values of office brachial systolic BP (SBP) and pulse pressure (PP), and 24-h, daytime, and nighttime central and brachial SBP and PP. They also had a blunted nocturnal decrease in both central and brachial BP, and higher values of aortic PWV. After adjustment for age, gender, and antihypertensive treatment, only ABPM-derived BP estimates (both central and brachial) 
Introduction
Cardiovascular (CV) risk assessment is based on measurement of peripheral or brachial BP. Central or aortic BP, however, is expected to better reflect the hemodynamic load on target organs. Indeed, clinical studies suggest that central BP shows a closer relationship with target organ damage than does brachial BP [1] [2] [3] . Preclinical heart damage assessed by left ventricular mass and large artery damage assessed by intima media thickness and pulse wave velocity (PWV) appear to be closely associated with central systolic BP (SBP) and central pulse pressure (PP) . Data on the relationship of central BP and renal organ damage are, however, conflicting [4] [5] [6] . It is widely known that 24-h ambulatory BP monitoring (ABPM) is a better predictor of target organ damage and CV risk than office BP [7] . ABPM provides a large number of BP measurements together with nighttime BP measurement, reflecting an important part of the hypertension-related load on the CV system. Technological advances in recent years have allowed the development of devices capable of estimating central 24-h ABPM noninvasively by the cuff-based oscillometric method (Mobil-O-Graph, IEM, Germany) [8, 9] . Estimation of 24-h central BP can improve CV risk assessment in arterial hypertension. Therefore, the aim of the present study was to evaluate the possible association between 24-h central hemodynamic BP indices and renal organ damage in hypertensive patients.
Materials and Methods

Study design
This was a cross-sectional study including 208 patients aged >18 years with a diagnosis of essential hypertension (mean age 57±12 years, 66% men) who were consecutively enrolled from five hypertension units at corresponding university hospitals in the metropolitan area of Barcelona, Spain. The study was approved by the local institutional ethics committees. Written informed consent was obtained from all participants.
Anthropometric and demographic characteristics, CV risk factors, and laboratory results were recorded at the inclusion visit for all participants. The following data were obtained: age, sex, weight, height, and family history of premature CV disease. Obesity was defined by a body mass index (BMI) ≥30 kg/m 2 . Other recorded variables were smoking habit, duration of hypertension, antihypertensive treatment prescribed, and previous history of CV disease (including heart failure, coronary heart disease, cerebrovascular disease, and symptomatic ischemic peripheral vascular disease). Diabetes mellitus was diagnosed using the medical history if the patient was under antidiabetic treatment or by two or more fasting plasma glucose determinations ≥7.0 mmol/L (126 mg/dL). Dyslipidemia was considered to be present if patients were being treated with lipid-lowering drugs and/or total cholesterol was >5 mmol/L (190 mg/dL), low-density lipoprotein cholesterol was >3.0 mmol/L (115 mg/dL), high-density lipoprotein cholesterol was <1.0 mmol/L (40 mg/dL) (men) or <1.2 mmol/L (46 mg/dL) (women), or triglycerides were >1.7 mmol/L (150 mg/dL).
BP measurements
All BP measurements were performed by means of a noninvasive automated oscillometric device (Mobil-O-Graph PWV, IEM, Stolberg, Germany), validated for brachial BP measurement, according to the European Society of Hypertension International protocol [9] . The monitor was placed on a working day, starting between 08:00 AM and 10:00 AM. After 5-min rest, BP was measured 4 times consecutively at 1-min intervals. The mean of these measurements served as the office BP. Thereafter, BP was measured automatically at 20-min intervals throughout both the awake and the asleep period, as defined in the patient's dairy. Inclusion of subjects in the study was contingent upon acquisition of recordings of good technical quality (at least 80% valid readings). If this criterion was not met, ABPM was repeated in one week.
Assessment of renal organ damage
Serum creatinine was measured by an enzymatic modified Jaffe reaction (CREA; Roche Diagnostics), consistent with the current recommendations for standardizing serum creatinine measurement. Urinary albumin excretion (measured by turbidimetry in local laboratories according to current recommended standards) was determined as the average of the ratio of albumin to creatinine in two spot first-morning void urine samples obtained on separate days. The eGFR was calculated using the Chronic Kidney DiseaseEpidemiology Collaborative equation (CKD-EPI) [10] .
Kidney disease was considered present if the patient had a urinary albumin excretion ≥30 mg/g creatinine and/or an eGFR <60 ml/min/1.73 m 2 .
Aortic pulse wave velocity
Aortic pulse wave velocity (aPWV) was measured by means of the Mobil-O-Graph device with the inbuilt ARCSolver method used for brachial and central 24-h BP assessment. The methodology for aPWV estimation has been previously reported and validated against invasive methods [11, 12] . A measurement was taken concomitant with each BP measurement and mean values for 24 h were computed.
Statistical analysis
Data are presented as mean ± standard deviation for normally distributed variables, median [interquartile range] for continuous variables that deviated from the normal distribution, or frequencies (%) for qualitative variables. Differences in clinical parameters and BP values between patients with or without renal damage were estimated by means of Student's t test, Mann-Whitney U-test, or Pearson's chi square test, as appropriate. The association of each BP estimate with the presence of renal damage was assessed by means of logistic regression analyses, with risk ratio calculation adjusted for age, gender, and the use of antihypertensive treatment. The SPSS for Windows version 18.0 software (SPSS Inc., Chicago, IL) was used for statistical analysis.
Results
Patients
Kidney data of hypertensive patients included in the study are shown in Table 1 . Thirtyfive patients (16.8%) had microalbuminuria and 28 (13.5%) had an eGFR <60 ml/min/1.73 m 2 . A total of 54 patients (25.9%) were affected by renal organ damage, as indicated by either microalbuminuria or eGFR <60 ml/min/1.73 m 2 . Clinical and demographic characteristics of the population with (n=54) and without (n=154) renal organ damage are shown in Table 2 . As expected, hypertensive patients with kidney damage were older and had higher BMI and higher rates of diabetes, dyslipidemia, and previous CV disease. Accordingly, patients with renal organ damage had higher plasma levels of glucose, HbA1c, uric acid, and triglycerides and were receiving a higher number of antihypertensive drugs. Clinical and demographic characteristics were further analyzed separately in patients with or without microalbuminuria and with or without reduced renal function. No distinctive features were directly associated with either microalbuminuria or reduced eGFR, with the exception of a poor metabolic profile, which differed between microalbuminuric and normoalbuminuric patients, but not between those with normal or reduced renal function (Table 3) . 
Office and 24-h ambulatory brachial and central BP
Office and 24-h ambulatory brachial and central BP are shown in Table 4 . Patients with renal damage had higher SBP and PP values, both brachial and central. The magnitude of the difference was generally more prominent for brachial than for central BP. Furthermore, patients with kidney damage showed a blunted nocturnal decrease in both brachial and central BP. In line with the PP increase, patients with renal damage also had higher office and ambulatory daytime, nighttime, and 24-h aortic PWV (Table 5) . Table 6 . Office and 24-h ambulatory brachial and central BP in hypertensive patients based on the presence or absence of microalbuminuria. Data are expressed as mean ± standard deviation. DBP: diastolic blood pressure; PP: pulse pressure; SBP: systolic blood pressure BP was further analyzed based on the type of renal abnormality. Patients with either microalbuminuria or reduced renal function had higher brachial and central BP, as well as a blunted nocturnal BP decline, compared to their counterparts without such abnormalities. Differences were more pronounced when comparing patients with and without microalbuminuria ( Table 6 ) than when comparing those with and without reduced renal function (Table 7) . In this latter comparison, and as regards central BP, only nocturnal PP was significantly higher in patients with impaired eGFR.
Risk of the presence of renal organ damage based on office and 24-h ambulatory brachial and central BP
The association of renal organ damage (indicated by either microalbuminuria or eGFR <60 ml/min/1.73 m 2 ) with office and 24-h ambulatory BP, both brachial and central, is shown in a Forest plot in Fig. 1 . After adjusting for age, gender, and antihypertensive treatment, only nighttime brachial SBP and 24-h, daytime, and nighttime brachial PP were significantly associated with renal organ damage. As regards central BP indices, significant associations were again present for 24-h, daytime, and nighttime PP. Confidence intervals for odds ratios of brachial and central BP show overlap, indicating that there were no differences between brachial and central estimates. Moreover, as shown in Table 8 , we calculated odds ratios for brachial and central BP estimates after simultaneous adjustments. None of the central estimates maintained its statistical significance after brachial adjustment.
Discussion
Classically, the diagnosis and management of hypertensive patients have been based on brachial or peripheral BP measurement in the office, and more recently this approach was extended to home measurement and 24-h ABPM. Technological advances have allowed the development of new devices capable of measuring central BP in a noninvasive way [13, 14] . Their development is based on the premise that central or aortic BP reflects the true load on the target organ. In fact, several studies have suggested that central BP is associated with the macrovascular damage, specifically cardiac and carotid damage, but is not so closely related to the microvascular lesion [2, 4, 6, [15] [16] [17] [18] . Kollias et al. analyzed four studies that showed similar correlations of urine albumin excretion with brachial SBP and central BP (three in Table 7 . Office and 24-h ambulatory brachial and central BP in hypertensive patients based on the presence or absence of reduced renal function. Data are expressed as mean ± standard deviation. ABPM: ambulatory BP monitoring; DBP: diastolic blood pressure; PP: pulse pressure; SBP: systolic blood pressure an office setting and one with ABPM) [2] . Goupil et al. also found that microalbuminuria and early chronic kidney disease were not associated with office central BP [5] . A previous study from our group showed similar correlation of microalbuminuria with office central BP and office brachial BP [18] . Finally, in a Chinese community, Fan et al. found that, compared with office brachial SBP, office central SBP was a stronger predictor for kidney function decline [6] . In all the studies discussed, central BP was measured by radial tonometry.
The widespread use of 24-h ABPM has revealed the importance of the BP circadian rhythm and the role of nocturnal BP in the prognosis of organ damage in hypertension [19] [20] [21] . In the present study, we evaluated the possible relationship between renal organ damage and central ABPM hemodynamic indices in hypertensive patients.
Twenty-six percent of the hypertensive patients included in the study had kidney damage, as indicated by either microalbuminuria or eGFR <60 ml/min/1.73 m 2 . These patients, as expected, had a worse CV profile, were older, had a higher BMI, and displayed higher rates of diabetes, dyslipidemia, and previous CV events.
Patients with renal damage showed worse BP control by ABPM, both brachial and central, mainly reflected in the SBP and PP values. It is known that DBP and mean BP are relatively constant along the vascular tree while the SBP increases as it moves away from the heart. Greater SBP amplification has been associated with vascular stiffness that induces higher PWV and early wave reflections [22] . Indeed, in this study patients with kidney damage showed an increase in aortic PWV, a known marker of vascular stiffness.
Regarding the BP circadian rhythm, it is known that patients with kidney damage show a blunted nocturnal decrease in brachial BP. In this study we confirmed this BP pattern, which was also altered at the central level [23, 24] .
The main result of the study is that we did not detect significant differences between brachial and central BP indices in patients with renal damage. It is known that kidney damage in hypertension is related to the degree to which renal autoregulatory mechanisms fail to prevent the high BP from being transmitted to the renal microvasculature. Vasoconstrictions of the preglomerular vasculature protect the rest of the renal vasculature from elevated pressure transmission [25] . Therefore, the kidney may not represent a typical target organ directly exposed to aortic pressure. This work suggests that in hypertensive patients with renal damage, optimal control of 24-h brachial BP will be sufficient to ensure renal protection.
The study has some limitations: First, due to the cross-sectional design we could not establish causality on the level of central BP with the lesion or CV event (pathogenic factor) or regression of the target organ damage. Second, the number of patients with renal abnormalities (either microalbuminuria or reduced renal function) was relatively low. The study has, however, important strengths: (1) use of a calibrated device, (2) absence of observer influence on the BP result due to ease of use of the device, (3) simultaneous assessment of 24-h monitoring of both brachial and central BP, and (4) the fact that microalbuminuria and eGFR are reliable markers of kidney damage.
In summary, this study suggests that cuff-based oscillometric central ABPM does not show superiority over brachial ABPM for the prediction of renal organ damage, as indicated by either microalbuminuria or eGFR, in treated hypertensive patients. More studies, however, need to be performed in a prospective and controlled manner in large hypertensive subpopulations to identify the real role of central BP in clinical practice, specifically in relation to BP control, target organ damage, CV events, CV risk evaluation, and guided pharmacological treatment.
